[HTML][HTML] New-age vaccine adjuvants, their development, and future perspective

SK Verma, P Mahajan, NK Singh, A Gupta… - Frontiers in …, 2023 - frontiersin.org
In the present scenario, immunization is of utmost importance as it keeps us safe and
protects us from infectious agents. Despite the great success in the field of vaccinology …

[PDF][PDF] Recent advances of vaccine adjuvants for infectious diseases

S Lee, MT Nguyen - Immune network, 2015 - synapse.koreamed.org
Vaccines are the most effective and cost-efficient method for preventing diseases caused by
infectious pathogens. Despite the great success of vaccines, development of safe and strong …

The path to a successful vaccine adjuvant–'the long and winding road'

DT O'Hagan, E De Gregorio - Drug discovery today, 2009 - Elsevier
New generation vaccines will increasingly comprise highly purified recombinant proteins.
Unfortunately, these antigens are often poorly immunogenic. Therefore, adjuvants will be …

Vaccine adjuvants: key tools for innovative vaccine design

P Riese, K Schulze, T Ebensen… - Current topics in …, 2013 - ingentaconnect.com
Vaccines represent the most efficient tool for preventing diseases caused by infectious
pathogens. During the last century significant progress has been made in vaccine …

[HTML][HTML] Key roles of adjuvants in modern vaccines

SG Reed, MT Orr, CB Fox - Nature medicine, 2013 - nature.com
Vaccines containing novel adjuvant formulations are increasingly reaching advanced
development and licensing stages, providing new tools to fill previously unmet clinical …

Survey of human-use adjuvants

R Edelman - Expert review of vaccines, 2003 - Taylor & Francis
Although there are only four adjuvants used in licensed vaccines for humans, a wealth of
information on novel vaccine adjuvants has become available in both animal models and …

Vaccine adjuvants: scientific challenges and strategic initiatives

AM Harandi, G Davies, OF Olesen - Expert review of vaccines, 2009 - Taylor & Francis
The majority of vaccine antigens currently under investigation represent recombinant
molecules or subunits of pathogens with little or no inherent immunostimulatory property …

[HTML][HTML] Towards an evidence based approach for the development of adjuvanted vaccines

DT O'Hagan, LR Friedland, E Hanon… - Current opinion in …, 2017 - Elsevier
Highlights•New adjuvants are typically a combination of delivery system and an immune
potentiator.•A deeper understanding of innate immunity has helped the discovery of new …

[HTML][HTML] The continued advance of vaccine adjuvants–'we can work it out'

DT O'Hagan, RN Lodaya, G Lofano - Seminars in immunology, 2020 - Elsevier
In the last decade there have been some significant advances in vaccine adjuvants,
particularly in relation to their inclusion in licensed products. This was proceeded by several …

[HTML][HTML] Mucosal vaccine adjuvants update

JH Rhee, SE Lee, SY Kim - Clinical and experimental …, 2012 - synapse.koreamed.org
Mucosal vaccination, capable of inducing protective immune responses both in the mucosal
and systemic immune compartments, has many advantages and is regarded as a blue …